NHS England said tens of thousands of children and adults with type 1 diabetes in the country will receive an artificial pancreas. The initiative includes hybrid closed-loop automated insulin delivery systems like Insulet’s Omnipod 5.
The initiative, long in the works, received support from the National Institute for Health and Care Excellence (NICE). In December, NICE published guidance recommending hybrid closed-loop systems for eligible people with type 1 diabetes in England and Wales. Following that government guidance, the NHS picked up funding and shared its plans to roll out the technology in January.
Get the full story at our sister site, Drug Delivery Business News.